Back to Search
Start Over
Regulation of bone mass in inflammatory diseases.
- Source :
- Best Practice & Research Clinical Endocrinology & Metabolism; Mar2022, Vol. 36 Issue 2, pN.PAG-N.PAG, 1p
- Publication Year :
- 2022
-
Abstract
- Inflammation is among the major determinants of bone loss in chronic disease and aging. Bone metabolism is radically affected by inflammation with consequent bone loss and increased fracture risk. Various cytokines and mediators are involved in the pathogenesis of bone loss in inflammatory conditions. The present review has the aim of discussing the main pathways involved in the pathogenesis of bone loss in inflammatory diseases, focusing in particular on the Wnt system and its regulators. Literature review of studies published between inception to 2021 on osteoporosis and inflammation was conducted. I will discuss the epidemiology of osteoporosis and fractures in common inflammatory diseases. The molecular basis of bone loss related to inflammation will be discussed as well. Finally, the effects of various anti-inflammatory medications on bone metabolism will be reviewed. [ABSTRACT FROM AUTHOR]
Details
- Language :
- English
- ISSN :
- 1521690X
- Volume :
- 36
- Issue :
- 2
- Database :
- Supplemental Index
- Journal :
- Best Practice & Research Clinical Endocrinology & Metabolism
- Publication Type :
- Academic Journal
- Accession number :
- 155722567
- Full Text :
- https://doi.org/10.1016/j.beem.2021.101611